Purchase Order 75N93023P01111
Award Date 8/25/23
Potential Completion Date 8/24/24
Potential Value $196K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gilbertville, Hardwick, MA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions in...
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Capralogics Inc. for $11,315 on January 13, 2021, to provide llama injections, maintenance, and sample shipping services for COVID-19 research. Work is performed in Gilbertville and Hardwick, Massachusetts. The order carries firm fixed pricing with an ultimate completion date of January 27, 2021.</p>
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order contract to Advanced Bioscience Laboratories, Inc. (ABL) on August 9, 2018, with a ceiling value of $12.9 million for current Good Manufacturing Practice (cGMP) manufacturing of PGT121 and PGDM1400 antibodies in support of preclinical development activities. The contract, which carries a cost-plus-fixed-fee pricing structure with no set-aside designation, is scheduled for completion by December 31, 2031,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Aalto Bio Reagents Limited, a for-profit limited liability company based in Ireland. The award, with a firm fixed price of $3,935.00, is for the purchase of 5 units of AMBIS 1699473 AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120 ANTIBODY at a unit price of $787.00 per unit. The contract does not have a set-aside designation and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Spring Valley Laboratories, Inc. for the provision of custom polyclonal antibody, polyclonal from exsanguination, and courier charges. The contract, valued at $3,557.61, was awarded on December 18, 2012 with a completion date of December 21, 2012. The contract type is a purchase order with a firm fixed price. There was no...
- A&G Pharmaceutical, Inc., operating as Precision Antibody, received a $15,500 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) on August 27, 2024, for laboratory testing, fusion, and cloning services. The contract, which carries no set-aside designation, is set to be completed by November 30, 2024, and will be performed in Columbia, Maryland. This award represents NIAID's continued investment in specialized biological research materials...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on June 29, 2017, with a ceiling value of $8,677,861.82 for nonhuman primate purchase and holding under the HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ. The order is priced on a cost-plus-fixed-fee basis with place of performance in Rockville, MD and an ultimate completion date of June 30, 2024. The parent IDIQ supports preclinical development services for...
- <p>The federal contract award HHSN272201401008P was granted to Hycult Biotech Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services. The contract is for the delivery of antibodies, valued at $3,346.75 on a firm fixed price basis. The contract was awarded on September 3, 2014 with an ultimate completion date of October 3, 2014. The contract does not have a set-aside designation.</p>
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS), to Pacific Immunology, a biotech company located in Ramona, California. The $9,996.33 firm fixed price purchase order is for monospecific antibody production services using rabbits. This contract is not set aside for any specific business category. Pacific Immunology has...